CG
DGX icon

Caprock Group’s Quest Diagnostics DGX Stock Holding History

Caprock Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
5,714
+799
+16% +$155K 0.03% 512
2025
Q4 		$853K Buy
+4,915
New +$895K 0.02% 642
2025
Q1 		$250K Sell
1,479
-1,749
-54% -$287K 0.01% 934
2024
Q4 		$487K Buy
3,228
+252
+8% +$39.2K 0.02% 630
2024
Q3 		$462K Sell
2,976
-283
-9% -$42.3K 0.02% 595
2024
Q2 		$446K Buy
3,259
+593
+22% +$81.2K 0.02% 561
2024
Q1 		$355K Sell
2,666
-38
-1% -$4.93K 0.02% 512
2023
Q4 		$373K Sell
2,704
-8
-0.3% -$1.05K 0.02% 474
2023
Q3 		$330K Sell
2,712
-77
-3% -$10.3K 0.03% 470
2023
Q2 		$392K Sell
2,789
-331
-11% -$45.6K 0.03% 433
2023
Q1 		$441K Buy
3,120
+8
+0.3% +$1.15K 0.03% 390
2022
Q4 		$487K Sell
3,112
-1,969
-39% -$283K 0.05% 288
2022
Q3 		$623K Sell
5,081
-56
-1% -$7.38K 0.06% 234
2022
Q2 		$683K Buy
5,137
+1,964
+62% +$268K 0.07% 216
2022
Q1 		$434K Buy
3,173
+36
+1% +$5.02K 0.04% 327
2021
Q4 		$543K Buy
3,137
+6
+0.2% +$913 0.04% 265
2021
Q3 		$455K Buy
3,131
+110
+4% +$16.1K 0.04% 276
2021
Q2 		$399K Sell
3,021
-195
-6% -$25.5K 0.04% 298
2021
Q1 		$413K Buy
+3,216
New +$396K 0.05% 267

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Caprock Group's DGX Position: Q1 2026 in Review

Caprock Group increased its Quest Diagnostics (DGX) stake by 16% in Q1 2026, buying an estimated $155K and bringing the position to 5,714 shares worth $1.12M. The position accounts for 0.03% of the portfolio, ranked #512.

Caprock Group first reported a position in DGX in Q1 2021 and has held it in 19 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Caprock Group held 5,714 shares of Quest Diagnostics worth $1.12M as of Q1 2026.
  • Caprock Group bought 799 Quest Diagnostics shares in Q1 2026, an estimated $155K.
  • Quest Diagnostics made up 0.03% of Caprock Group's portfolio in Q1 2026, its #512 holding.
  • Caprock Group first reported a position in Quest Diagnostics in Q1 2021 and has held it in 19 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.